Observations from ID and Beyond: FDA's Emergency Use Authorization for Convalescent Plasma for COVID-19 Seems To Be Fooling No One

In HIV and ID Observations, Dr. Paul Sax discusses why the FDA issued an emergency use authorization for convalescent plasma for COVID-19, despite the absence of published, peer-reviewed data.

After “a little intimidation” from the president, the FDA granted an emergency use authorization for investigational convalescent plasma for treating COVID-19 in hospitalized patients. Thankfully, says Dr. Paul Sax in in the latest HIV and ID Observations blog post, no one in the scientific community is fooled.

Want to see more from NEJM Journal Watch? Register here.

Observations from ID and Beyond: FDA's Emergency Use Authorization for Convalescent Plasma for COVID-19 Seems To Be Fooling No One

Topics